Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
GSK secures option to multiple high-value, validated Alzheimer’s-relevant targets for drug discovery, development, and commercialization
The celebrations began with the unveiling of the Biocon Anthem
Subscribe To Our Newsletter & Stay Updated
